Structure for peptidase M17.008: M17 aminopeptidase (Plasmodium spp.)
 
| TERTIARY STRUCTURE DATA | ||||||||
|---|---|---|---|---|---|---|---|---|
| Comment | Resolution | PDB | PDBe | SCOP | CATH | PDBSum | Proteopedia | Reference |
| Plasmodium falciparum | ||||||||
| mature peptidase | 2.01 Å | 3KQX | 3KQX | 3KQX | 3KQX | 3KQX | 3KQX | |
| mature peptidase | 2.39 Å | 3KQZ | 3KQZ | 3KQZ | 3KQZ | 3KQZ | 3KQZ | |
| mature peptidase | 2.00 Å | 3KR4 | 3KR4 | 3KR4 | 3KR4 | 3KR4 | 3KR4 | |
| mature peptidase | 2.56 Å | 3KR5 | 3KR5 | 3KR5 | 3KR5 | 3KR5 | 3KR5 | |
| a bestatin-based chemical biology strategy reveals distinct roles for malaria m1- and m17-family aminopeptidases | 2.00 Å | 3T8W | 3T8W | 3T8W | 3T8W | 3T8W | 3T8W | |
| phosphonic arginine mimetics as inhibitors of the m17 aminopeptidases from plasmodium falciparum | 2.00 Å | 4K3N | 4K3N | 4K3N | 4K3N | 4K3N | 4K3N | |
| complex witha hydroxamic acid-based inhibitor | 2.60 Å | 4R6T | 4R6T | 4R6T | 4R6T | 4R6T | 4R6T | |
| complex witha hydroxamic acid-based inhibitor | 2.85 Å | 4R7M | 4R7M | 4R7M | 4R7M | 4R7M | 4R7M | |
| x-ray crystal structure of the orally available aminopeptidase inhibitor, tosedostat, bound to the m17 leucyl aminopeptidase from p.falciparum | 2.73 Å | 4X2T | 4X2T | 4X2T | 4X2T | 4X2T | 4X2T | |
